Related Experiment Video
Updated: Jan 22, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Myocardial fibrosis in chagas disease and molecules related to fibrosis
Ana T Chaves1, Cristiane A S Menezes2, Henrique S Costa1
1Programa de Pós-Graduação em Ciências da Saúde: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil.
Insights
Chronic Chagas cardiomyopathy (CCC) causes significant heart disease and poor prognosis. This review explores how myocardial fibrosis in CCC links to cardiac arrhythmias, highlighting the need for noninvasive biomarkers.
Area of Science:
- Cardiology
- Pathophysiology
- Biomarkers
Background:
- Chronic Chagas cardiomyopathy (CCC) is a leading cause of morbidity and mortality.
- CCC presents unique characteristics compared to other cardiomyopathies, notably extensive myocardial fibrosis.
- The disease disrupts the extracellular matrix, promoting arrhythmogenic foci and complex arrhythmias.
Purpose of the Study:
- To investigate the association between myocardial fibrosis distribution/degree and cardiac arrhythmogenicity in Chagas cardiomyopathy.
- To emphasize the significance of noninvasive biomarkers for quantifying myocardial fibrosis in CCC patients.
Main Methods:
- This review synthesizes existing research on CCC pathophysiology and clinical management.
- Focuses on studies examining myocardial fibrosis and its correlation with arrhythmias.
- Highlights the role of noninvasive biomarkers in fibrosis assessment.
Main Results:
- CCC is characterized by significant myocardial fibrosis, disrupting the heart's extracellular matrix.
- This fibrosis creates an environment conducive to the development of arrhythmogenic foci.
- CCC is highly arrhythmogenic, leading to complex arrhythmias and conduction disorders.
Conclusions:
- A strong link likely exists between myocardial fibrosis patterns and cardiac arrhythmogenicity in CCC.
- Noninvasive biomarkers are crucial for assessing myocardial fibrosis and managing arrhythmogenicity in Chagas patients.
- Further research into fibrosis-arrhythmia correlation can improve CCC patient outcomes.
Abstract:
Chronic Chagas cardiomyopathy (CCC) is responsible for the disease's greater morbidity and poor prognosis. Although understanding the pathophysiology of CCC and the fundamentals of its clinical management derives from research related to other cardiomyopathies, there are peculiarities that distinguish CCC from the others. CCC is the most fibrous heart disease, and its myocardial involvement is important as it disorganizes or disrupts the extracellular matrix, creating an environment conducive to the formation of arrhythmogenic foci. It is also considered the most arrhythmogenic of the known heart diseases, giving rise to complex arrhythmias, usually associated with varying degrees of stimulus conduction disorders. The central proposal of this review is to describe a possible association between the distribution and degree of myocardial fibrosis and cardiac arrhythmogenicity in patients with Chagas cardiomyopathy, drawing attention to the importance of noninvasive biomarkers for the quantification of myocardial fibrosis.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Molecules and Compounds
Types of Signaling Molecules
Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion
Positive Regulator Molecules

